While the long-term consequences of diabetes are a major focus of care, the acute complications—Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and hypoglycemia—are medical emergencies that require immediate and precise management. Pharmacists play a critical role in both the prevention and treatment of these conditions, a topic covered in detail in the Patient Care 5 curriculum. This quiz will test your knowledge on the pathophysiology and therapeutic management of these life-threatening diabetic emergencies.
1. A patient with diabetes feels shaky, sweaty, and anxious. Their blood glucose is 60 mg/dL. This condition is known as:
- a. Hyperglycemia
- b. Hypoglycemia
- c. Diabetic Ketoacidosis (DKA)
- d. Hyperosmolar Hyperglycemic State (HHS)
Answer: b. Hypoglycemia
2. The “Rule of 15” for treating hypoglycemia involves consuming 15 grams of a simple carbohydrate and then:
- a. Injecting 15 units of insulin.
- b. Rechecking blood glucose in 15 minutes.
- c. Waiting 15 minutes before taking any other action.
- d. Eating a high-fat meal.
Answer: b. Rechecking blood glucose in 15 minutes.
3. Diabetic Ketoacidosis (DKA) is most commonly associated with which type of diabetes?
- a. Type 1 Diabetes
- b. Type 2 Diabetes
- c. Gestational Diabetes
- d. Prediabetes
Answer: a. Type 1 Diabetes
4. The three key diagnostic features of DKA are hyperglycemia, ketosis, and:
- a. Metabolic alkalosis
- b. Anion gap metabolic acidosis
- c. A normal anion gap
- d. Respiratory acidosis
Answer: b. Anion gap metabolic acidosis
5. What is the most critical first step in the management of a patient with severe DKA or HHS?
- a. Administering IV regular insulin.
- b. Administering subcutaneous long-acting insulin.
- c. Administering IV fluid resuscitation with normal saline.
- d. Administering oral glucose tablets.
Answer: c. Administering IV fluid resuscitation with normal saline.
6. The “Management of DKA/HHS” is a specific lecture in which course?
- a. PHA5787C Patient Care 5
- b. PHA5104 Sterile Compounding
- c. PHA5703 Pharmacy Law and Ethics
- d. PHA5878C Patient Care 3
Answer: a. PHA5787C Patient Care 5
7. Which type of insulin is used for a continuous IV infusion to treat DKA?
- a. Insulin glargine
- b. NPH insulin
- c. Insulin aspart
- d. Regular insulin
Answer: d. Regular insulin
8. Before starting an insulin infusion for a patient in DKA, which electrolyte must be checked and corrected if it is too low (<3.3 mEq/L)?
- a. Sodium
- b. Calcium
- c. Potassium
- d. Phosphate
Answer: c. Potassium
9. Hyperosmolar Hyperglycemic State (HHS) differs from DKA in that HHS is characterized by:
- a. More severe ketoacidosis.
- b. Its occurrence only in Type 1 Diabetes.
- c. Profound hyperglycemia and severe dehydration with minimal or no ketosis.
- d. A low serum osmolality.
Answer: c. Profound hyperglycemia and severe dehydration with minimal or no ketosis.
10. What is the purpose of administering glucagon?
- a. To treat severe hyperglycemia.
- b. To treat severe hypoglycemia in a patient who is unable to take oral carbohydrates.
- c. To correct acidosis in DKA.
- d. To lower blood pressure.
Answer: b. To treat severe hypoglycemia in a patient who is unable to take oral carbohydrates.
11. The management of diabetes complications is a topic within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
12. Why does insulin administration cause a drop in serum potassium levels?
- a. It increases renal excretion of potassium.
- b. It causes potassium to shift from the extracellular space into the intracellular space.
- c. It binds to potassium in the bloodstream.
- d. It does not affect potassium levels.
Answer: b. It causes potassium to shift from the extracellular space into the intracellular space.
13. Which of the following is a common precipitating factor for DKA or HHS?
- a. An infection, such as pneumonia or a UTI.
- b. Nonadherence to insulin therapy.
- c. A new diagnosis of Type 1 Diabetes.
- d. All of the above.
Answer: d. All of the above.
14. A patient being treated for DKA has their blood glucose fall to 220 mg/dL. The insulin infusion should be stopped.
- a. True
- b. False
Answer: b. False
15. Educating a patient on how to monitor a health condition like blood glucose is a key objective for student pharmacists.
- a. True
- b. False
Answer: a. True
16. When a patient’s blood glucose reaches ~200 mg/dL during DKA treatment, what should be added to their IV fluids?
- a. Bicarbonate
- b. Potassium
- c. Dextrose
- d. Normal saline
Answer: c. Dextrose
17. The pathophysiology of diabetes is a topic within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
18. Kussmaul respirations (deep, rapid breathing) are a compensatory mechanism for which acid-base disorder seen in DKA?
- a. Metabolic alkalosis
- b. Respiratory acidosis
- c. Metabolic acidosis
- d. Respiratory alkalosis
Answer: c. Metabolic acidosis
19. Which of the following is a neuroglycopenic symptom of hypoglycemia?
- a. Shaking
- b. Sweating
- c. Tachycardia
- d. Confusion and difficulty speaking
Answer: d. Confusion and difficulty speaking
20. An active learning session on diabetes, including its acute complications, is part of the Patient Care 5 course.
- a. True
- b. False
Answer: a. True
21. A patient taking which class of oral diabetes medications is at the highest risk for hypoglycemia?
- a. Metformin
- b. SGLT2 inhibitors
- c. Sulfonylureas
- d. TZDs
Answer: c. Sulfonylureas
22. The “fruity” odor on the breath of a patient in DKA is caused by:
- a. High blood glucose.
- b. The exhalation of acetone.
- c. The breakdown of proteins.
- d. The IV fluids being administered.
Answer: b. The exhalation of acetone.
23. What is the role of a pharmacist in managing a DKA patient in the hospital?
- a. Preparing the IV insulin infusion.
- b. Recommending appropriate fluid and electrolyte replacement.
- c. Developing and managing the institution’s DKA protocol.
- d. All of the above.
Answer: d. All of the above.
24. An active learning session on diabetes is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
25. Which of the following is NOT a component of DKA management?
- a. Fluid resuscitation
- b. Insulin therapy
- c. Electrolyte management
- d. A high-carbohydrate diet
Answer: d. A high-carbohydrate diet
26. A patient is considered to have severe hypoglycemia when:
- a. Their blood glucose is < 70 mg/dL.
- b. They can self-treat with oral carbohydrates.
- c. They require external assistance from another person to treat.
- d. They feel shaky.
Answer: c. They require external assistance from another person to treat.
27. HHS is more common in which patient population?
- a. Young children with Type 1 Diabetes.
- b. Elderly patients with Type 2 Diabetes.
- c. Pregnant patients.
- d. Athletes.
Answer: b. Elderly patients with Type 2 Diabetes.
28. An active learning session on diabetes is part of which course module?
- a. Module 1: Diabetes Mellitus
- b. Module 3: Women’s Health
- c. Module 4: Medication Safety
- d. Module 8: Men’s Health
Answer: a. Module 1: Diabetes Mellitus
29. The anion gap is calculated to help differentiate the causes of:
- a. Metabolic alkalosis
- b. Respiratory acidosis
- c. Metabolic acidosis
- d. Respiratory alkalosis
Answer: c. Metabolic acidosis
30. The management of diabetes is a lecture within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
31. What is the main reason for adding dextrose to IV fluids once the blood glucose normalizes during DKA treatment?
- a. To provide calories.
- b. To allow the insulin infusion to continue to resolve the ketoacidosis without causing hypoglycemia.
- c. To treat dehydration.
- d. To correct hyperkalemia.
Answer: b. To allow the insulin infusion to continue to resolve the ketoacidosis without causing hypoglycemia.
32. A patient with hypoglycemia should avoid treating it with a chocolate bar because:
- a. It does not contain enough sugar.
- b. The fat content can delay the absorption of sugar.
- c. It contains too much protein.
- d. It can cause an allergic reaction.
Answer: b. The fat content can delay the absorption of sugar.
33. What is the primary cause of the severe dehydration seen in DKA and HHS?
- a. Decreased fluid intake.
- b. Vomiting.
- c. Osmotic diuresis caused by profound hyperglycemia.
- d. Fever and sweating.
Answer: c. Osmotic diuresis caused by profound hyperglycemia.
34. A key part of patient education is counseling on how to prevent hypoglycemia by:
- a. Skipping meals.
- b. Taking extra insulin before exercise.
- c. Monitoring blood glucose regularly and balancing food, activity, and medication.
- d. Always keeping blood glucose above 200 mg/dL.
Answer: c. Monitoring blood glucose regularly and balancing food, activity, and medication.
35. A pharmacist should ensure that any patient on insulin is also counseled on and prescribed a(n):
- a. Metformin tablet
- b. SGLT2 inhibitor
- c. Glucagon emergency kit
- d. ACE inhibitor
Answer: c. Glucagon emergency kit
36. The anion gap is elevated in DKA due to the accumulation of:
- a. Lactic acid
- b. Bicarbonate
- c. Ketoacids (e.g., beta-hydroxybutyrate)
- d. Chloride
Answer: c. Ketoacids (e.g., beta-hydroxybutyrate)
37. Which of the following is NOT a symptom of hypoglycemia?
- a. Tachycardia
- b. Diaphoresis (sweating)
- c. Polydipsia (excessive thirst)
- d. Dizziness
Answer: c. Polydipsia (excessive thirst)
38. The lecture “Management of DKA/HHS” is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
39. A patient’s serum osmolality would be expected to be higher in which condition?
- a. DKA
- b. HHS
- c. Mild hypoglycemia
- d. They would be equal in DKA and HHS.
Answer: b. HHS
40. An active learning session covering acute diabetes complications is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
41. The initial insulin therapy for DKA/HHS is:
- a. An IV bolus followed by a continuous infusion.
- b. A subcutaneous injection of long-acting insulin.
- c. A continuous infusion only, without a bolus.
- d. An intramuscular injection.
Answer: a. An IV bolus followed by a continuous infusion.
42. Which patient is at highest risk for developing HHS?
- a. A 15-year-old with newly diagnosed Type 1 diabetes.
- b. A 75-year-old with Type 2 diabetes and a pneumonia infection.
- c. A 30-year-old pregnant patient.
- d. A 45-year-old on metformin only.
Answer: b. A 75-year-old with Type 2 diabetes and a pneumonia infection.
43. A pharmacist’s role includes identifying medications that can cause hypoglycemia, such as sulfonylureas and:
- a. Metformin
- b. Insulin
- c. SGLT2 inhibitors
- d. DPP-4 inhibitors
Answer: b. Insulin
44. What is a key counseling point for nasal glucagon (Baqsimi)?
- a. It requires assembly before use.
- b. It should be inhaled deeply.
- c. It does not require inhalation; it is absorbed through the nasal mucosa.
- d. It must be refrigerated.
Answer: c. It does not require inhalation; it is absorbed through the nasal mucosa.
45. Once a patient with DKA is stable, eating, and the acidosis has resolved, they should be transitioned to:
- a. An oral diabetes medication.
- a. A scheduled subcutaneous basal-bolus insulin regimen.
- c. A sliding scale insulin regimen only.
- d. No further insulin therapy.
Answer: b. A scheduled subcutaneous basal-bolus insulin regimen.
46. A patient taking a beta-blocker may have which symptom of hypoglycemia masked?
- a. Sweating
- b. Hunger
- c. Tachycardia and shakiness
- d. Confusion
Answer: c. Tachycardia and shakiness
47. A patient with DKA will have a ____ pH and a ____ serum bicarbonate.
- a. high, high
- b. high, low
- c. low, high
- d. low, low
Answer: d. low, low
48. An active learning session on diabetes complications is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
49. The overall management of a hyperglycemic crisis requires:
- a. Insulin therapy alone.
- b. Frequent monitoring of blood glucose and electrolytes.
- c. Addressing the precipitating cause.
- d. Both b and c.
Answer: d. Both b and c.
50. The ultimate goal of learning about the acute complications of diabetes is to:
- a. Be able to manage life-threatening emergencies effectively and educate patients on how to prevent them.
- b. Memorize the diagnostic criteria for DKA.
- c. Pass the endocrinology exam.
- d. Become an expert in IV fluid preparation.
Answer: a. Be able to manage life-threatening emergencies effectively and educate patients on how to prevent them.
